Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review.

American journal of medical genetics. Part A - 1 Nov 2019

de Boer Janna, Boot Erik, van Gils Lissa, van Amelsvoort Therese, Zinkstok Janneke

Abstract excerpt

The 22q11.2 deletion syndrome (22q11.2DS) is a multisystem condition and the most prevalent microdeletion syndrome in humans. Approximately 25% of individuals with 22q11.2DS receive antipsychotic treatment. To assess whether patients with 22q11.2DS are vulnerable to adverse effects of antipsychotic medication, we carried out a literature review. A systematic search strategy was performed using PubMed (Medline),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DiGeorge Syndrome

Share to Drug-Related Side Effects and Adverse Reactions

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 31407842
DOI: 10.1002/ajmg.a.61324
PMCID: PMC6851664

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review.PMID 31407842Read ↗

Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion SyndromeSemantic proximity Read ↗

[New interdisciplinary S3 guidelines on deletion syndrome 22q11.2, a genetic disease predisposing to neuropsychiatric morbidity].Semantic proximity Read ↗

Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical ImplicationsSemantic proximity Read ↗

Schizophrenic Phenotype and Therapeutic Course Associated With Chromosome 22q11.2 Deletion in a Cohort Without Prior Diagnosis of Chromosome 22q11.2 Deletion Syndrome.Semantic proximity Read ↗

[Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].Semantic proximity Read ↗

A review of antipsychotic therapy effectiveness and tolerability among individuals with copy number variants relevant to schizophrenia.Semantic proximity Read ↗

The Neuropsychiatry of 22q11.2 Deletion Syndrome: An Electronic Health Records StudySemantic proximity Read ↗

Dissecting the Phenotypic Spectrum and Complexity of Movement Disorders in 22q11.2 Deletion Syndrome.Semantic proximity Read ↗

[Chromosome 22q11 deletion syndrome and its relevance for child and adolescent psychiatry. An overview of etiology, physical symptoms, aspects of child development and psychiatric disorders].Semantic proximity Read ↗

Antipsychotic Use Among Intellectually Disabled Individuals With Rare Genetic Variants That Confer Risk for Schizophrenia.Semantic proximity Read ↗

Epilepsy and Other Neuropsychiatric Manifestations in Children and Adolescents with 22q11.2 Deletion SyndromeSemantic proximity Read ↗

Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.